The tolerogenic microenvironment of the liver is associated with impaired hepatic T cell function. Here, we examined the contribution of liver-resident natural killer (LrNK) cells, a prominent hepatic NK cell compartment, to T cell antiviral responses in the liver. The number of virus-specific T cells increased in LrNK-cell-deficient mice during both acute and chronic lymphocytic choriomeningitis virus infection. Upon infection with adenovirus, hepatic T cells from these mice produced more cytokines, which was accompanied by reduced viral loads. Transfer of LrNK cells into LrNK-cell-deficient or wild-type mice inhibited hepatic T cell function, resulting in impaired viral clearance, whereas transfer of conventional NK cells promoted T cell antiviral responses. LrNK-cell-mediated inhibition of T cell function was dependent on the PD-1-PD-L1 axis. Our findings reveal a role for LrNK cells in the regulation of T cell immunity and provide insight into the mechanisms of immune tolerance in the liver.
Pubmed ID: 30709740 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD274 (B7-H1, PD-L1)
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets Mouse Trail
View all literature mentionsThis monoclonal targets CD3e
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis monoclonal targets CD335
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets CD275
View all literature mentionsThis monoclonal targets IL-2
View all literature mentionsThis monoclonal targets CD200R
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD27
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD200R
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets Perforin
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets Mouse Granzyme B PE 25 ug
View all literature mentionsThis monoclonal targets CD39
View all literature mentionsThis monoclonal targets Mouse DR5 (Trail-R2, TrailR2)
View all literature mentionsThis monoclonal targets CD73
View all literature mentionsThis monoclonal targets Mouse Trail
View all literature mentionsThis monoclonal targets CD274
View all literature mentionsThis monoclonal targets CD49b (Integrin α2 chain)
View all literature mentionsThis monoclonal targets CD49b/Pan-NK Cells
View all literature mentionsThis monoclonal targets CD107a (LAMP-1)
View all literature mentionsThis monoclonal targets CD49a (Integrin α1 chain)
View all literature mentionsThis monoclonal targets Mouse CD8a
View all literature mentionsThis monoclonal targets CD49a
View all literature mentionsThis monoclonal targets Mouse CD4
View all literature mentionsThis monoclonal targets CD19
View all literature mentions